AIR PRODUCTS AND CHEMICALS, INC. (APD): what the price assumes
In the published model solve dated 2026-Q2, anchored at $308.09, AIR PRODUCTS AND CHEMICALS, INC. (APD) is priced for today's economics sustained for ~5.3 years. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-07-25.
Generated: 2026-08-30 · Source: https://boothcheck.com/report/APD
Headline
| Field | Value |
|---|---|
| Ticker | APD |
| Company | AIR PRODUCTS AND CHEMICALS, INC. |
| Sector / Industry | Basic Materials |
| Current price | $308.09/sh |
| Composition | On-site 51% / Merchant 44% / Sale of equipment 4% |
What The Price Assumes (Inversion)
The assumption today's price embeds, recovered by inverting the valuation.
| Field | Value |
|---|---|
| Inversion basis | whole-company |
| Operating margin (value-band context) | 17.4% |
| Operating margin (mid-cycle) | 14.7% |
| Margin expansion (value-band) | +2.7pp |
| Trailing margin (depressed year) | -4.7% |
| Must persist for | 5.3y |
| Multiple paid | 46x mid-cycle operating income |
The operating-margin figure is value-band context at year 12: derived from the framework's value band, a separate calculation — not part of the priced-in solve.
Solve inputs: computed at a 7.4% cost of capital; growth searched up to the 25% self-funding ceiling.
How unusual the bet is: n/a
| Reference | Value |
|---|---|
| vs own history | +0.81σ |
Valuation X-Ray
Asset, earnings-power and peer-multiple models all land far below the price; ONLY the growth-DCF reaches it. The bet is durable compounding the static frames structurally cannot price (a moat/durability premium).
How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.
| Family | Median price/FV | Models | Reads |
|---|---|---|---|
| Asset | 5.22x | 2 | expensive |
| Earnings | 2.69x | 1 | expensive |
| Relative | 3.63x | 3 | expensive |
| Growth | 1.20x | 2 | expensive |
Families that justify the price: Growth Families that call it expensive: Asset, Earnings, Relative
The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 9.2%); the inversion above states its own rate.
Per-Model Detail (n=8)
| Model | Family | FV | Price/FV | Applicable | Methodology |
|---|---|---|---|---|---|
| DCF Perpetual Growth | Growth | $287.60 | 1.07x | yes | Reference only (OCF-based, capex excluded): OCF $3.3B |
| DCF Exit Multiple | Growth | $0.00 | — | no | Negative/zero FCF or EBITDA — equity value floored at $0 |
| Relative Valuation | Relative | $84.89 | 3.63x | yes | P/S fallback (negative EPS): Sector P/S 1.5x × TTM revenue — excluded from consensus |
| Simple DDM | Growth | — | — | no | — |
| Two-Stage DDM | Growth | — | — | no | — |
| Simple Excess Return | Asset | $62.35 | 4.94x | yes | Reference only (book value floor): BV/sh $62.35, ROE negative |
| Two-Stage Excess Return | Asset | $56.11 | 5.49x | yes | Reference only (book value with convergence): BV/sh $62.35, ROE converges to ke |
| Discounted Future Market Cap | Growth | $232.34 | 1.33x | yes | Rev $12.6B, growth 5% (input: historical growth; tapered), Terminal P/S: 4.6x / 5.4x / 6.3x (bear / base = today's held flat / bull, cap 8x) |
| Peter Lynch Fair Value | Relative | $0.00 | — | no | Negative/zero EPS — earnings-based value floored at $0 |
| Margin Trajectory | Growth | — | — | no | — |
| Earnings Power Value | Earnings | $114.60 | 2.69x | yes | Normalized EBIT (5y avg op income, one-time charges added back) $2.94B × (1−21%) / WACC 9.2% → EPV (no growth) |
| Residual Income | Asset | — | — | no | — |
| Graham Number | Asset | — | — | no | — |
| EV/EBITDA Relative | Relative | $91.43 | 3.37x | yes | EBITDA $2.50B × sector EV/EBITDA 8.0x |
| FCF Yield | Earnings | — | — | no | — |
| SBC-Adj FCF Yield | Earnings | — | — | no | — |
| Ben Graham Formula | Earnings | — | — | no | — |
| ROIC-Justified P/B | Asset | — | — | no | — |
| P/Sales Sector | Relative | $84.89 | 3.63x | yes | Revenue $12.60B × sector P/S 1.5x |
| PEG Fair Value | Relative | — | — | no | — |
| Earnings Yield | Earnings | — | — | no | — |
| Funds From Operations Multiple | Relative | — | — | no | — |
| Clinical Phase NPV | Growth | — | — | no | — |
| Merton | Asset | — | — | no | — |
| V5 Mechanical | — | — | — | no | — |
Solvency
| Field | Value |
|---|---|
| Net debt | $16.8b |
| Net debt / NOPAT (after-tax) | 11.50x |
| Net debt / operating income (pre-tax) | 9.08x |
| Interest coverage | 8.4x |
| Share count CAGR (dilution) | 0.0% |
| Burning cash | no |
Leverage and coverage are computed on normalized mid-cycle operating income (mid-cycle margin 14.7%); the trailing year was depressed.
Bullet Takeaways
- Just over half of revenue comes through the on-site supply mode, which the 10-K describes as "governed by contracts that are generally long-term in nature with provisions that allow us to pass through changes in energy costs to our customers", and that pass-through is why the regional businesses run margins near 30% while much of the chemicals sector runs losses.
- The price is the risk: at $297.94 the market pays roughly 47 times what the company earns at the operating line through a full cycle, and no standard valuation family reaches that level.
- Fiscal third-quarter results arrive on July 30, 2026, the first check on management's April decision to raise the full-year outlook while holding capital spending near $4.0 billion.
Bull Case
Here is the number that does not fit the story anyone tells about this company. Over the trailing twelve months, Air Products reported an operating loss of $50.2 million. In the March 2026 quarter alone it reported $753 million of operating income at a 23.7% margin, with earnings per share of $3.19. Both figures are real and neither is a typo. The trailing line is dominated by write-downs on projects the company walked away from; the quarterly line is what the gas business does when nobody is cleaning up. A buyer today is choosing which of those two numbers describes the asset.
The reason to think it is the second one sits in how the revenue is contracted. The 10-K puts it plainly: "Approximately half our total revenue is generated through the on-site supply mode, which is governed by contracts that are generally long-term in nature with provisions that allow us to pass through changes in energy costs to our customers." An on-site plant is built behind a refinery or a steel mill, connected by pipe, and paid for over years by a customer who cannot switch without rebuilding the plumbing. Energy, the largest input, moves through to that customer rather than into the margin. That is a genuinely unusual position in a sector where most companies are price takers at both ends.
Break the revenue down by region and the earning power is easy to see. The Americas contribute about 45% of revenue and run at 31.1%, Europe about 25% and runs at 28.7%, Asia about 29% and runs at 26.6%. Now look at what surrounds this name in the materials sector: Westlake (WLK) ran an operating margin of negative 15.7%, LyondellBasell (LYB) negative 1.0%, Albemarle (ALB) negative 2.8%, and Tronox (TROX) negative 8.0%. Only Linde (LIN), the other industrial gas major, keeps company at 26.5%. Industrial gases share a stock-market label with commodity chemicals and almost nothing else.
Management's forecasting record supports taking its guidance at face value rather than discounting it. Since 2006 the guidance ledger runs 24 raises and 15 reaffirmations against a single withdrawal, and the most recent entry was another raise: full-year fiscal 2026 adjusted earnings guidance moved up in April. For a business whose earnings depend on project timing, that is a management team that has generally known what was coming.
None of this makes the price cheap, and a bull who pretends otherwise is not paying attention. The argument is narrower: the trailing income statement understates the business by a wide margin, the contracted half of revenue is close to an annuity, and the assets being built now are the ones the multiple is waiting on.
Bear Case
Start with what a share costs, because everything else is commentary on it. At $297.94, the market pays roughly 47 times what this company earns at the operating line across a full cycle. Not one family of valuation method reaches that. Methods built on asset value land about 2.4 times under the quote, methods built on earnings power about 2.6 times under, and peer multiples about 2.4 times under. Even the forward-growth methods, the ones built to credit future expansion, land below the current quote. For the price to be right, today's economics have to hold at their limit for about 5.3 years. Of companies that have run at that level, only about 32% kept it up that long.
That is the structural truth: this is priced as though the cycle has been abolished, by a business that just spent a year proving it has not. The trailing operating result of negative $50.2 million is the arithmetic residue of project cancellations and write-downs, and the 10-K describes exactly the mechanism that produced them, warning of "project delays, scope changes, cost escalations, contract terminations, customer cancellations, or postponement of projects and sales" and noting that a delay may force the company "to cancel a project and/or compensate the customer for the delay, which may also cause us to incur material costs that we may be unable to recover."
The annuity is also smaller than the reputation. About half the revenue is contracted long-term, which leaves the merchant half, and the filing is specific about what that half is not: "Sales of both liquid bulk and packaged gases do not include minimum purchase requirements, as they are governed by contracts and/or purchase orders that reflect the customer's specific needs. These contracts contain stated terms that are generally five years or less." Merchant volumes track industrial production. When the customers who buy them run negative margins, as several in this cohort currently do, the orders thin out.
Then the balance sheet, which is carrying more than it looks. Net debt of $17.1 billion is about 9.5 times operating profit measured through the cycle, and operating profit covers the interest bill 8.7 times over. Against that, capital spending is running near $4.0 billion a year. The share count has not moved over the four years to March 2026, so none of the cash is coming back that way. A company spending that heavily, at that leverage, at that multiple, has no room for a second bad project cycle.
The final dependency is one the company names itself. A portion of the growth pipeline rests on decarbonisation demand, and the 10-K does not hide the conditionality: "certain of our green and blue hydrogen projects are largely based on expected demand for technologies and projects to limit the impact of global climate change. Demand for our solutions could be negatively impacted if the public and private sectors reduce their focus on reducing carbon emissions." That is a policy variable dressed as a growth plan, and policy has already moved once during the life of these projects.
Valuation
The bet embedded in $297.94 is about duration, not about a rate. The market is paying roughly 47 times what the business earns at the operating line through a full cycle, and that multiple requires today's economics to persist at their limit for about 5.3 years. History is not encouraging on that specific question: of companies operating at that level, only about 32% sustained it that long. The read on the assumption comes out elevated, which is a statement about how rarely the requirement has been met rather than a forecast about this company.
Every family of method lands below the price, which is unusual and worth stating plainly. Methods built on asset value sit about 2.4 times under the quote, methods built on earnings power about 2.6 times under, and peer multiples about 2.4 times under. Even the forward-growth methods, which exist precisely to credit expansion the static frames cannot see, come in below today's level. There is no family here for the price to hide behind, and that is the single most informative fact in this section.
The trailing income statement is the wrong lens and it is worth saying why. Operating income over the last twelve months was negative $50.2 million because of write-downs, while net income was $2.107 billion. The multiple above is therefore computed on through-the-cycle economics rather than on the trough: a mid-cycle operating margin near 14.7% applied to about $12.5 billion of revenue. That normalization is generous to the company, not harsh, which makes the resulting multiple more striking rather than less.
Where the revenue comes from shapes how durable those economics are. About 51% arrives through on-site supply, 44% through merchant, and 4% through equipment sales. The on-site half is the contracted piece, described in the 10-K as "generally long-term in nature with provisions that allow us to pass through changes in energy costs to our customers." The merchant half carries no such protection: "These contracts contain stated terms that are generally five years or less." Regionally the earning power is concentrated in the Americas, which contributes about 45% of revenue and runs at 31.1%, with Europe running at 28.7% and Asia at 26.6%.
The balance sheet does not bound the downside so much as extend it. Net debt of $17.1 billion runs at about 9.5 times operating profit measured through the cycle, with interest covered 8.7 times, and the share count is unchanged across the four years to March 2026. Against that, the guidance ledger since 2006 shows 24 raises and 15 reaffirmations against a single withdrawal, which is a management team that has been reliable about the next twelve months. The multiple, though, is not asking about the next twelve months.
Catalysts
The fiscal second quarter, reported on April 30, 2026, was the quarter that changed the trajectory of the numbers. Sales of $3.2 billion rose 9% on higher volumes, favourable currency and higher energy cost pass-through, offset in part by weaker helium pricing. Operating income of $753 million and earnings per share of $3.19 each rose more than 130% against the prior-year quarter, which had carried heavy charges, and the reported operating margin came in at 23.7%.
Management raised the outlook in the same release. Full-year fiscal 2026 adjusted earnings per share guidance went to a range of $13.00 to $13.25, up from $12.85 to $13.15, with fiscal third-quarter adjusted earnings per share guided to $3.25 to $3.35. Capital spending guidance for fiscal 2026 was held near $4.0 billion, so the improvement in earnings is not coming from a reduced investment programme.
Fiscal third-quarter results are scheduled for July 30, 2026 at 8:00 a.m. Eastern time. The specific things that release will settle are whether the non-helium pricing actions taken earlier in the year are showing up in the second half as management indicated, and whether the newly commissioned assets are ramping on the schedule the capital programme assumes.
Peer Cohorts (Per Segment, With Filing Citations)
Core business (reported)
- LIN (LINDE PLC)
- FY2025 10-K: …20 Segment Discussion 25 Liquidity, Capital Resources and Other Financial Data 30 Off-Balance Sheet Arrangements 32 Critical Accounting Estimates 32 New Accounting Standards 34 Fair Value Measurements 34 Non-GAAP Financial Measures 35 Supplemental Guarantee Information 38 17 Table of Contents BUSINESS OVERVIEW The…
- FY2025 10-K: …reporting purposes is segment operating profit. Segment operating profit is defined as operating profit excluding purchase accounting impacts of the Linde AG merger, cost reduction program and other charges, and items not indicative of ongoing business trends. This is the manner in which the company's Chief Operating…
- DD (DUPONT DE NEMOURS, INC.)
- FY2025 10-K: …not subject to future reimbursement ("Stranded Costs"). Stranded Costs are reported within continuing operations in Corporate and are included within Operating EBITDA. The Company's measure of profit/loss for segment reporting purposes is Operating EBITDA as this is the manner in which the Company's chief operating…
- FY2025 10-K: …respond to competitive conditions and customer preferences. Demand for the Company's products, which impacts revenue and profit margins, is affected by (i) the development and timing of the introduction of competitive products; (ii) the Company's response to downward pricing trends to stay competitive; (iii) changes…
- WLK (Westlake Corporation)
- FY2025 10-K: …rates and lower margins. Moreover, profitability in the petrochemical industry is affected by the worldwide level of demand along with vigorous price competition which may intensify due to, among other things, new industry capacity. In general, weak economic conditions reduce demand and put pressure on margins. It is…
- FY2025 10-K: …OpCo's primary ethylene co-products are chemical grade propylene, crude butadiene, pyrolysis gasoline and hydrogen. We have storage agreements and exchange agreements that provide us and OpCo with access to customers who are not directly connected to the pipeline system that we own. OpCo ships crude butadiene and…
- LYB (LYONDELLBASELL INDUSTRIES N.V.)
- FY2025 10-K: …well as smaller specialty applications. Our customers use our plastics and chemicals to manufacture a wide range of products that people use in their everyday lives, including food packaging, home furnishings, automotive components, paints and coatings. We also develop and license chemical and polyolefin process…
- FY2025 10-K: …is dependent on market-driven demand for olefins and polyolefins. Sales prices for products sold in the spot market are determined by market forces. Our contract prices are influenced by product supply and demand conditions, spot prices, indices published in industry publications and, in some instances, cost recovery…
- EMN (EASTMAN CHEMICAL CO)
- FY2025 10-K: …and operational excellence. Examples include produced acetic anhydride used in the manufacturing of cellulosic biopolymers and acetyl stream product lines, propylene and ethylene used in the production of olefin derivative product lines such as oxo alcohols and plasticizers. The CI segment also provides superior…
- FY2025 10-K: …on specific facts and circumstances, impact the Company's competitive position. See "Risk Factors -- Legislative, regulatory, or voluntary actions could increase the Company's future health, safety, and environmental compliance costs." in Part I, Item 1A of this Annual Report. These include health, safety, and…
- ALB (Albemarle Corporation)
- FY2025 10-K: …Our raw material and energy costs can be volatile and may increase significantly. Increases are primarily driven by tightening of market conditions and major increases in the pricing of key constituent materials for our products such as crude oil, chlorine and metals (including molybdenum and rare earths, which are…
- FY2025 10-K: …epoxies and other engineered resins. Competition Our Ketjen segment serves the global market including the Americas, Asia, Europe and the Middle East, each of which is highly competitive. Competition in these markets is driven by a variety of factors. Product performance, quality, price, contract terms, product and…
- TROX (TRONOX HOLDINGS PLC)
- FY2025 10-K: …of raw materials, utilities, transportation and similar costs rise, our operating expenses will increase and could adversely affect our business, especially if we are unable to pass price increases relating to raw materials, utilities, transportation and similar costs through to our customers. The markets for many of…
- FY2025 10-K: …our businesses. These operations use modern techniques and equipment and accordingly require various types of skilled workers. The success of our business will be materially dependent upon the skills, experience and efforts of our key officers and skilled employees. Competition for skilled employees may cost us in…
- CBT (Cabot Corporation)
- FY2025 10-K: …economic characteristics and if the operating segments are similar in the following areas: i) nature of products and services; ii) nature of production processes; iii) type or class of customer for their products and services; iv) methods used to distribute the products or provide services; and v) if applicable, the…
- FY2025 10-K: …Industry Risks Our industry is highly competitive and demand for our products and our financial results may be negatively impacted by changes in industry capacity utilization, a material shift in the geographic area of tire production (in particular, shifts away from higher margin regions), and competition from other…
Methodology Note
- Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
- Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
- Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
- Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.
Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.
Sources
Air Products fiscal 2026 second quarter results, April 30, 2026 · Air Products earnings teleconference announcement, July 15, 2026